BLRX
BioLineRX
BLRX
BLRX
21 hedge funds and large institutions have $4.6M invested in BioLineRX in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.08M | |
| 2 | +$124K | |
| 3 | +$103K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$90K |
| 5 |
LPL Financial
San Diego,
California
|
+$65.5K |
Top Sellers
| 1 | -$2.77M | |
| 2 | -$1.14M | |
| 3 | -$543K | |
| 4 |
O
OrbiMed
New York
|
-$114K |
| 5 |
Morgan Stanley
New York
|
-$91K |